Cannabigerol for Psychological and Physiological Effects (CBG Trial)

N/A

Recruiting

Research Sponsored by Washington State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

21+ years of age

Be older than 18 years old

Must not have

History of diabetes

History of chronic neurological disorders (e.g., head injuries, brain tumors, Parkinson's disease)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up mood ratings will occur within a 2.5 hour time frame for each session with sessions scheduled approximately one week apart

Summary

This trial aims to investigate how cannabigerol (CBG) affects both mental and physical health outcomes in humans. Researchers will look at things like anxiety, stress, mood, memory, blood pressure

Who is the study for?

This trial is for individuals interested in participating in a study to assess the effects of cannabigerol (CBG), a compound found in cannabis. There are no specific conditions listed, so participants may be from the general population.

What is being tested?

The study is testing how CBG affects psychological aspects like anxiety, mood, and memory, as well as physiological responses such as blood pressure and heart rate. Participants will receive either CBG or a placebo to compare outcomes.

What are the potential side effects?

Potential side effects of CBG include sleepiness or fatigue, dry mouth or eyes, increased appetite, dizziness, and nausea. These will be monitored throughout the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 21 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a history of diabetes.

Select...

I have a history of chronic neurological disorders.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ mood ratings will occur within a 2.5 hour time frame for each session with sessions scheduled approximately one week apart

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~mood ratings will occur within a 2.5 hour time frame for each session with sessions scheduled approximately one week apart

This trial's timeline: 3 weeks for screening, Varies for treatment, and mood ratings will occur within a 2.5 hour time frame for each session with sessions scheduled approximately one week apart for reporting.